---
title: "Dexmedetomidine Hydrochloride Injection Shortage: Updates on Manufacturer Availability"
summary: "The FDA has reported a current shortage of Dexmedetomidine Hydrochloride Injection, an anesthesia medication, primarily due to shipping delays and manufacturer discontinuations."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Dexmedetomidine","Injection"]
location: "United States"
severity: "medium"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-11T14:40:44.000Z
---
### What's in Shortage

Dexmedetomidine Hydrochloride Injection is currently listed in shortage by the FDA. This medication, which falls under the therapeutic category of anesthesia, is available under the generic name Dexmedetomidine Hydrochloride Injection and brand names including Dexmedetomidine Hydrochloride and Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride. The shortage affects various presentations, including 4 mcg/mL, 100 mcg/1 mL, 200 mcg/2 mL, and 400 mcg/100 mL concentrations.

This shortage was first posted on April 10, 2020, and was last updated on February 5, 2026.

### Which Manufacturers Are Affected

Availability varies significantly across different suppliers:

*   **Fresenius Kabi USA, LLC**: Currently **Unavailable** for multiple presentations (4 ug/1 mL and 100 ug/1 mL). Contact: 888-386-1300.
*   **Accord Healthcare Inc.**: Currently **Unavailable**. One presentation has been discontinued, while another has a resupply date that is currently To Be Determined (TBD). Contact: 866-941-7875, option 2.
*   **Amneal Pharmaceuticals**: Currently **Available** (4 mcg/mL in 50 mL and 100 mL). Contact: 877-835-5472 or 866-525-7270.
*   **Mylan Institutional, a Viatris Company**: Currently **Available** (100 ug/1 mL). Contact: 800-796-9526.
*   **Jiangsu Hengrui Pharmaceuticals Co., Ltd.**: Currently **Available**. These products are marketed by Sandoz Inc. (800-525-8747) or distributed by Avenacy (877-283-6229).
*   **Baxter Healthcare**: Currently **Available** (200 ug/50 mL). Contact: 888-229-0001.
*   **Par Health, USA LLC**: Currently **Available** (4 ug/1 mL). Contact: 800-828-9393.

### Why There's a Shortage

The primary reason cited for the current shortage is a delay in the shipping of the drug. Additionally, Accord Healthcare Inc. has reported the discontinuation of the manufacture of specific presentations of the medication.

### What Patients Should Do

Dexmedetomidine Hydrochloride is an injection typically administered by healthcare professionals in clinical or hospital settings for anesthesia. If you or a loved one are scheduled for a procedure requiring this medication, please consider the following steps:

*   **Consult Your Healthcare Provider**: Speak with your doctor or the clinical staff at the facility where the procedure will take place to discuss the availability of the medication.
*   **Contact Manufacturers**: For the most up-to-date information regarding specific supply levels, you may contact the manufacturers listed above using the provided phone numbers.
*   **Pharmacist Consultation**: Hospital pharmacists are often the first to know about supply shifts and can provide information on current inventory.

*Disclaimer: Patients should always consult their healthcare provider regarding medication changes or concerns. This article does not provide medical advice or recommend specific alternatives.*

### Source

Information provided by the FDA Drug Shortage Database.